Who is Signing ACTA: State of Play Cont’d
ACTA to Be Signed – But Can it Enter into Force? It has been reported in global press this week that ACTA will be signed October 1 in Japan. But that does not mean that ACTA actually goes into…
Category Trade Agreements
ACTA to Be Signed – But Can it Enter into Force?
It has been reported in the global press this week that ACTA will be signed October 1 in Japan. But that does not mean that ACTA actually goes into effect. ACTA Article 40 states that the “Agreement shall enter into…
Obama’s Deficit Plan Would Reduce Data Exclusivity for Biologics and Ban Pay-for-Delay Patent Settlements
The Obama administration’s proposal to reduce U.S. deficits contains two provisions dealing with intellectual property and healthcare. The proposal would reduce data exclusivity for biologic medicines to 7 years (from the current period of 12 years), and would “prohibit additional…
USTR Tables IP Text and Releases White Paper on Trade and Access to Medicines at the Chicago TPP Negotiating Round
Last week the U.S. tabled additional text on intellectual property at the Trans Pacific Partnership negotiating round in Chicago. The text is confidential, but trade officials told reporters that it includes TRIPS-Plus measures affecting access to medicines such as”stronger patent…
Statement of Sean Flynn on USTR Release of White Paper on “Trans Pacific PartnershipTrade Goals to Enhance Access to Medicines”
The statement of the administration today continues its practice of actively thwarting the release of meaningful information about its positions in closed door international law making. The statement says little about what the administration’s actual trade policy on medicines issues…
At TTP Negotiating Round, USTR Holds Firm on Secrecy and IP Maximalism
Here is some of what we learned at the TPP negotiation in Chicago this week. Transparency will be worse than ACTA. In response to the repeated calls in civil society and academic presentations for TPP negotiators to increase transparency in…
Global Congress Issues Washington Declaration on Intellectual Property and the Public Interest
With the U.S. round of the Trans-Pacific Partnership Agreement (TPPA) underway in Chicago, intellectual property and information policy experts from around the world have released a Washington Declaration on Intellectual Property and the Public Interest that challenges the dominant direction…
MEDIA ADVISORY: Fair Trade Advocates from U.S., New Zealand & Australia to Provide Update on Trans-Pacific Partnership
Public Citizen Conference Call Briefing on Trade Negotiations Underway in the United States Contact: Arthur Stamoulis arthur@citizenstrade.org WHAT: Fair trade advocates from the United States, New Zealand and Australia will provide a press briefing via conference call on key…
TPP Negotiators to Meet in Chicago for Two-Week Round: Reports Show the Conflict Between IP Provisions and Local Laws in the U.S. and Australia
The next negotiating round of the Trans Pacific Partnership Agreement will be held in Chicago from September 6-15. Negotiators hope to make progress on outstanding issues including intellectual property protection, which has been an area in which negotiators have had…
U.S. Presses Chile to Strengthen Data Exclusivity and Patent Linkage for Pharmaceuticals
Inside U.S. Trade reports that the US government urged Chile “to strengthen the system by which patent owners can challenge the approval of allegedly infringing generic pharmaceuticals to be sold in that market, and its protection of test data used…
PRESS BRIEFINGS – Release of EU Greens Draft Analysis of ACTA – Analysis of the Trans Pacific Partnership Agreement
WEBCAST August 25, 2011 10:00 Release of EU Greens Draft Analysis of ACTA 11:00 Analysis of the Trans Pacific Partnership Agreement CONTACTS: Megan Smith | megans@wcl.american.edu | 202-274-4276 Sean Flynn | sflynn@wcl.american.edu | 202-294-5749 Draft Reports: Draft Report:…
Seven Members of Congress: No 12 Year Periods of Data Exclusivity in the TPP
Earlier this month, seven members of Congress wrote President Obama to “strongly recommend that the United States refrain from negotiating any provisions related to exclusivity for biosimilar medicines” in the Trans Pacific Partnership. The letter from Reps. Waxman, McDermott, Stark,…